M-M-R II

Measles, Mumps, and Rubella Vaccine · Merck & Co.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for M-M-R II, covering 2010-02-10 to 2018-06-28. Get the full timeline:

Most recent: Clinical Trial Update: Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age [Phase 3]

See pricing